Carbohydrate metabolic pathway genes associated with quantitative trait loci (QTL) for obesity and type 2 diabetes: Identification by data mining

Biotechnology Journal

Volumn 5, Issue 9, 2010, Pages 942-949

  Varma, Vijayalakshmi ^a   Wise, Carolyn ^a   Kaput, Jim ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Carbohydrate metabolism genes; CNVs; Nutrigenomics; QTL; SNPs

Indexed keywords

CARBOHYDRATE METABOLISM GENES; CNVS; NUTRIGENOMICS; QTL; SNPS;

CARBOHYDRATES; DATA MINING; METABOLISM; NUTRITION;

GENES;

ARTICLE; CARBOHYDRATE INTAKE; CARBOHYDRATE METABOLISM; CARBOHYDRATE TRANSPORT; COPY NUMBER VARIATION; DATA MINING; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRIGENOMICS; OBESITY; PHENOTYPE; PHENOTYPIC VARIATION; POPULATION GENETICS; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RISK ASSESSMENT; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURAL GENE;

CARBOHYDRATE METABOLISM; CHROMOSOME MAPPING; CHRONIC DISEASE; DATA MINING; DIABETES MELLITUS, TYPE 2; HUMANS; METABOLIC NETWORKS AND PATHWAYS; NUTRIGENOMICS; OBESITY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI;

EID: 77956668605     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201000067     Document Type: Article

References (59)

1. Haslam, D. W., James, W. P., Obesity. Lancet 2005, 366, 1197-1209.
2. Bray, G. A., Medical consequences of obesity. J. Clin. Endocrinol. Metab. 2004, 89, 2583-2589.
3. Saris, W. H., Sugars, energy metabolism, and body weight control. Am. J. Clin. Nutr. 2003, 78, 850S-857S.
4. Siri-Tarino, P. W., Sun, Q., Hu, F. B., Krauss, R. M., Saturated fat, carbohydrate, and cardiovascular disease. Am. J. Clin. Nutr. 2010, 91, 502-509.
5. Malik, V. S., Popkin, B. M., Bray, G. A., Despres, J. P., Hu, F. B., Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 2010, 121, 1356-1364.
6. Boling, C. L., Westman, E. C., Yancy, W. S. Jr., Carbohydrate-restricted diets for obesity and related diseases: An update. Curr. Atheroscler. Rep. 2009, 11, 462-469.
7. Wylie-Rosett, J., Davis, N. J., Low-carbohydrate diets: An update on current research. Curr. Diab. Rep. 2009, 9, 396-404.
8. Schaefer, E. J., Gleason, J. A., Dansinger, M. L., Dietary fructose and glucose differentially affect lipid and glucose homeostasis. J. Nutr. 2009, 139, 1257S-1262S.
9. Hofmann, S. M., Tschop, M. H., Dietary sugars: A fat difference. J. Clin. Invest. 2009, 119, 1089-1092.
10. Havel, P. J., Dietary fructose: Implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr. Rev. 2005, 63, 133-157.
11. Tappy, L., Le, K. A., Metabolic effects of fructose and the worldwide increase in obesity. Physiol. Rev. 2010, 90, 23-46.
12. Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C. et al., Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Invest. 2009, 119, 1322-1334.
13. De Silva, N. M., Frayling, T. M., Novel biological insights emerging from genetic studies of type 2 diabetes and related metabolic traits. Curr. Opin. Lipidol. 2010, 21, 44-50.
14. Zeggini, E., Ioannidis, J. P., Meta-analysis in genome-wide association studies. Pharmacogenomics 2009, 10, 191-201.
15. Ridderstrale, M., Groop, L., Genetic dissection of type 2 diabetes. Mol. Cell. Endocrinol. 2009, 297, 10-17.
16. Walley, A. J., Asher, J. E., Froguel, P., The genetic contribution to non-syndromic human obesity. Nat. Rev. Genet. 2009, 10, 431-442.
17. Myles, S., Davison, D., Barrett, J., Stoneking, M., Timpson, N., Worldwide population differentiation at disease-associated SNPs. BMC Med. Genomics 2008, 1, 22.
18. Myles, S., Tang, K., Somel, M., Green, R. E. et al., Identification and analysis of genomic regions with large between-population differentiation in humans. Ann. Hum. Genet. 2008, 72, 99-110.
19. Freeman, J. L., Perry, G. H., Feuk, L., Redon, R. et al., Copy number variation: New insights in genome diversity. Genome Res. 2006, 16, 949-961. (Pubitemid 44162254)
20. Barnes, M. R., Breen, G., A short primer on the functional analysis of copy number variation for biomedical scientists. Methods Mol. Biol. 2010, 628, 119-135.
21. Barnes, M. R., Genetic variation analysis for biomedical researchers: A primer. Methods Mol. Biol. 2010, 628, 1-20.
22. Bassett, A. S., Marshall, C. R., Lionel, A. C., Chow, E. W., Scherer, S. W., Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome. Hum. Mol. Genet. 2008, 17, 4045-4053.
23. Dhawan, D., Padh, H., Pharmacogenetics: Technologies to detect copy number variations. Curr. Opin. Mol. Ther. 2009, 11, 670-680.
24. Fanciulli, M., Petretto, E., Aitman, T. J., Gene copy number variation and common human disease. Clin. Genet. 2010, 77, 201-213.
25. Ku, C. S., Loy, E. Y., Salim, A., Pawitan, Y., Chia, K. S., The discovery of human genetic variations and their use as disease markers: Past, present and future. J. Hum. Genet. 2010.
26. Williams, H. J., Owen, M. J., O'Donovan, M. C., Schizophrenia genetics: New insights from new approaches. Br. Med. Bull. 2009.
27. Ionita-Laza, I., Rogers, A. J., Lange, C., Raby, B. A., Lee, C., Genetic association analysis of copy-number variation (CNV) in human disease pathogenesis. Genomics 2009, 93, 22-26.
28. Barnes, P., Adams, P., Powell-Griner, E., Health characteristics of the Asian adult population: United States, 2004-2006. Advance Data from Vital Health Statistics 2008, 394, 1-24.
29. Kaput, J., Developing the promise of nutrigenomics through complete science and international collaborations. Forum Nutr. 2007, 60, 209-223.
30. Singh, G. K., Siahpush, M., Kogan, M. D., Rising social inequalities in US childhood obesity, 2003-2007. Ann. Epidemiol. 2010, 20, 40-52.
31. Razak, F., Anand, S. S., Shannon, H., Vuksan, V. et al., Defining obesity cut points in a multiethnic population. Circulation 2007, 115, 2111-2118. (Pubitemid 46659062)
32. James, W. P. T., Assessing obesity: Are ethnic differences in body mass index and waist classification criteria justified? Obes. Rev. 2005, 6, 179-181.
33. Pinto, D., Marshall, C., Feuk, L., Scherer, S. W., Copy-number variation in control population cohorts. Hum. Mol. Genet. 2007, 16 Spec No. 2, R168-173.
34. Shaikh, T. H., Gai, X., Perin, J. C., Glessner, J. T. et al., High-resolution mapping and analysis of copy number variations in the human genome: A data resource for clinical and research applications. Genome Res. 2009, 19,1682-1690.
35. Barton, N. H., Keightley, P. D., Understanding quantitative genetic variation. Nat. Rev. Genet. 2002, 3, 11-21.
36. Xu, Z., Wise, C., Varma, V., Fang, H. et al., Two new Array- TrackTM libraries for personalized biomedical research. BMC Bioinformatics 2010, in press.
37. Muller, M. J., Bosy-Westphal, A., Krawczak, M., Genetic studies of common types of obesity:A critique of the current use of phenotypes. Obes. Rev. 2010, 11, 612-618.
38. Wang, K., Chen, Z., Tadesse, M. G., Glessner, J. et al., Modeling genetic inheritance of copy number variations. Nucleic Acids Res. 2008, 36, e138.
39. Redon, R., Ishikawa, S., Fitch, K. R., Feuk, L. et al., Global variation in copy number in the human genome. Nature 2006, 444, 444-454. (Pubitemid 44809057)
40. Warodomwichit, D., Shen, J., Arnett, D. K., Tsai, M. Y. et al., ADIPOQ polymorphisms, monounsaturated fatty acids, and obesity risk:The GOLDN study. Obesity (Silver Spring) 2009, 17, 510-517.
41. Warodomwichit, D., Arnett, D. K., Kabagambe, E. K., Tsai, M. Y. et al., Polyunsaturated fatty acids modulate the effect of TCF7L2 gene variants on postprandial lipemia. J. Nutr. 2009, 139, 439-446.
42. Smith, C. E., Ordovas, J. M., Fatty acid interactions with genetic polymorphisms for cardiovascular disease. Curr. Opin. Clin. Nutr. Metab. Care 2009.
43. Liu, C., Wu, Y., Li, H., Qi, Q. et al., MTNR1B rs10830963 is associated with fasting plasma glucose, HbA1C and impaired beta-cell function in Chinese Hans from Shanghai. BMC Med. Genet. 2010, 11, 59.
44. Xing, C., Cohen, J. C., Boerwinkle, E., A weighted false discovery rate control procedure reveals alleles at FOXA2 that influence fasting glucose levels. Am. J. Hum. Genet. 2010, 86, 440-446.
45. Ruchat, S. M., Rankinen, T., Weisnagel, S. J., Rice, T. et al., Improvements in glucose homeostasis in response to regular exercise are influenced by the PPARG Pro12Ala variant: Results from the HERITAGE Family Study. Diabetologia 2010, 53, 679-689.
46. Rich, S. S., Goodarzi, M. O., Palmer, N. D., Langefeld, C. D. et al., A genome-wide association scan for acute insulin response to glucose in Hispanic-Americans: The Insulin Resistance Atherosclerosis Family Study (IRAS FS). Diabetologia 2009, 52, 1326-1333.
47. Sabatti, C., Service, S. K., Hartikainen, A. L., Pouta, A. et al., Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat. Genet. 2009, 41, 35-46.
48. Goldstein, D. B., Common genetic variation and human traits. N. Engl. J. Med. 2009, 360, 1696-1698.
49. Augustin, R., The protein family of glucose transport facilitators: It's not only about glucose after all. IUBMB Life 2010, 62, 315-333.
50. Ardehali, H., Tiller, G. E., Printz, R. L., Mochizuki, H. et al., A novel (TA)n polymorphism in the hexokinase II gene: Application to noninsulin-dependent diabetes mellitus in the Pima Indians. Hum. Genet. 1996, 97, 482-485.
51. Ristow, M., Vorgerd, M., Mohlig, M., Schatz, H., Pfeiffer, A., Deficiency of phosphofructo-1-kinase/muscle subtype in humans impairs insulin secretion and causes insulin resistance. J. Clin. Invest. 1997, 100, 2833-2841. (Pubitemid 28007553)
52. Elam, M. B., Cowan, G. S. Jr., Rooney, R. J., Hiler, M. L. et al., Hepatic gene expression in morbidly obese women: Implications for disease susceptibility. Obesity (Silver Spring) 2009, 17, 1563-1573.
53. Hani, E. H., Zouali, H., Philippi, A., Beaudoin, J. C. et al., Indication for genetic linkage of the phosphoenolpyruvate carboxykinase (PCK1) gene region on chromosome 20q to non-insulin-dependent diabetes mellitus. Diabetes Metab. 1996, 22, 451-454.
54. Ruchat, S. M., Elks, C. E., Loos, R. J., Vohl, M. C. et al., Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies. Acta Diabetol. 2009, 46, 217-226.
55. Eny, K. M., Wolever, T. M., Fontaine-Bisson, B., El-Sohemy, A., Genetic variant in the glucose transporter type 2 is associated with higher intakes of sugars in two distinct populations. Physiol. Genomics 2008, 33, 355-360.
56. Perry, G. H., Dominy, N. J., Claw, K. G., Lee, A. S. et al., Diet and the evolution of human amylase gene copy number variation. Nat. Genet. 2007, 39, 1256-1260.
57. Siva, N., 1000 Genomes project. Nat. Biotechnol. 2008, 26, 256.
58. Kaput, J., Cotton, R. G., Hardman, L., Watson, M. et al., Planning the Human Variome Project: The Spain report. Hum. Mutat. 2009, 30, 496-510.
59. Kaput, J., Nutrigenomics research for personalized nutrition and medicine. Curr. Opin. Biotechnol. 2008, 19, 110-120.